# Human Behavioral Pharmacology of Substance Abuse

> **NIH NIH T32** · JOHNS HOPKINS UNIVERSITY · 2024 · $626,100

## Abstract

PROJECT SUMMARY
Substance use disorders occur at the interface of behavior and pharmacology. This is a proposal to renew an
ongoing and successful postdoctoral clinical research training program on the human behavioral pharmacology
of substance abuse, for its 41st thru 45th years. Nine training positions are proposed, all at the postdoctoral
level. Training duration is two to three years. The goal is to produce experts in various aspects of substance
abuse, psychopharmacology, and treatment who go on to succeed as independent clinical researchers,
scientists, academicians, and administrators in drug abuse and related fields. The program has a long and
successful history, with many distinguished graduates. The program will provide training and experience in
translational experimental clinical trials research methods, extending from the human laboratory to the clinic.
Training consists primarily of conducting supervised clinical research in collaboration with training faculty and
analyzing and publishing the results, conclusions and implications of that research. Trainees attend and report
at major scientific meetings and participate in an organized program of educational seminars designed to
provide both breadth and depth to their knowledge and skills relevant to drug abuse and clinical research. The
training program site is a multifaceted drug abuse clinical research program -- the Behavioral Pharmacology
Research Unit -- plus other affiliated drug abuse treatment and research programs, primarily on the same
campus, but extending more broadly into the community as well. Research training is provided in the following
areas: clinical pharmacology of drugs of abuse; medications development research; the cognitive
neuroscience and behavioral toxicity of drugs of abuse; abuse liability assessment; pharmacological treatment
of drug abuse; behavioral treatment of drug abuse, especially incentive-based strategies; integration of
behavioral and pharmacological treatments; psychiatric and medical comorbidity; behavioral and
neuropsychiatric assessment; HIV risk behavior assessment; promotion of engagement and adherence; and
clinical trials research methods and trials management. Training includes a broad range of abused drug
classes – opioids, cocaine, prescription medications, cannabis, club drugs/psychedelics, alcohol,
tobacco/nicotine, and caffeine.

## Key facts

- **NIH application ID:** 10831444
- **Project number:** 5T32DA007209-44
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** Eric C. Strain
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $626,100
- **Award type:** 5
- **Project period:** 1981-02-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10831444

## Citation

> US National Institutes of Health, RePORTER application 10831444, Human Behavioral Pharmacology of Substance Abuse (5T32DA007209-44). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10831444. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*